On Wednesday, Alzamend Neuro, Inc. (NASDAQ:ALZN) announced it had completed the head coil by Tesla Dynamic Coils BV. The development of the head coil was necessary to facilitate Alzamend's five ...
Please provide your email address to receive an email when new articles are posted on . Tesla Coil may offer therapeutic drug monitoring for those with certain neuropsychiatric conditions. Alzamend ...
Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in healthy, Alzheimer’s disease, ...
Alzamend Neuro, Inc. (NASDAQ:ALZN) on Tuesday announced the initiation of the first of five Phase 2 clinical studies of AL001, with the first study in healthy human subjects. This study follows the ...